Jointown Pharmaceutical Group Co Ltd

Common Name
Jointown Pharmaceutical Group
Country
China (Mainland)
Sector
Healthcare
Industry
Medical Distribution
Employees
30,169
Ticker
600998
Exchange
SHANGHAI STOCK EXCHANGE
Description
Jointown Pharmaceutical Group Co., Ltd. is a comprehensive pharmaceutical company based in China. It primarily engages in the distribution and wholesale of pharmaceutical products, including active ph...
GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Jointown Pharmaceutical Group's GHG Emissions Data Preview

In 2024, Jointown Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Jointown Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Jointown Pharmaceutical Group’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Jointown Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.

a. Jointown Pharmaceutical Group's Sustainability Report 2024
a. Jointown Pharmaceutical Group's Sustainability Report 2024

Insights into Jointown Pharmaceutical Group's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Jointown Pharmaceutical Group amounted to 47,929.41 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Jointown Pharmaceutical Group's Scope 1 Emissions Over Time

202409.5 k19 k28.5 k38 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Jointown Pharmaceutical Group's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Jointown Pharmaceutical Group were 36,924.21 metric tons of CO₂ equivalent (tCO₂e). a

What are Jointown Pharmaceutical Group's Scope 2 emissions?

In 2024, Jointown Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 11,005.2 tCO₂e without specifying the calculation method. a

What methodology does Jointown Pharmaceutical Group use for Scope 2 reporting?

In 2024, Jointown Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology. a

Jointown Pharmaceutical Group's Scope 2 Emissions Over Time

202403 k6 k9 k12 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Jointown Pharmaceutical Group’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Jointown Pharmaceutical Group reported Scope 1 greenhouse gas (GHG) emissions of 36,924.21 tCO₂e and total revenues of USD 20,801 millions. This translates into an emissions intensity of 1.78 tCO₂e per millions USD. a

Jointown Pharmaceutical Group's Scope 1 Emissions Intensity Compared to Peers

0.5202,000200,00010,000,000Scope 1 Emissions (tCO2e)51001,00020,000200,000Revenues (Millions of USD)JAASPBDCJJJJD Health InternationalYear: 2023Scope 1: 175 tCO2eRevenue: $M 8,200Scope 1 Intensity: 0.02 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MEverest MedicinesYear: 2023Scope 1: 0 tCO2eRevenue: $M 19Scope 1 Intensity: 0.02 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MSSSinopharm GroupYear: 2024Scope 1: 48,786 tCO2eRevenue: $M 87,180Scope 1 Intensity: 0.56 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MKangji Medical HoldingsYear: 2023Scope 1: 164 tCO2eRevenue: $M 143Scope 1 Intensity: 1.15 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MJoinn Laboratories ChinaYear: 2023Scope 1: 319 tCO2eRevenue: $M 334Scope 1 Intensity: 0.96 tCO2e/$MMicroPort MedBotYear: 2023Scope 1: 68 tCO2eRevenue: $M 16Scope 1 Intensity: 4.19 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MWeigao GroupYear: 2024Scope 1: 3,096 tCO2eRevenue: $M 1,952Scope 1 Intensity: 1.59 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MBBBaiyunshan Pharmaceutical HoldingsYear: 2024Scope 1: 34,043 tCO2eRevenue: $M 10,276Scope 1 Intensity: 3.31 tCO2e/$MSichuan Kelun PharmaceuticalYear: 2024Scope 1: 2,361,763 tCO2eRevenue: $M 2,989Scope 1 Intensity: 790.21 tCO2e/$MMGI TechYear: 2023Scope 1: 18 tCO2eRevenue: $M 409Scope 1 Intensity: 0.04 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MYuwellYear: 2023Scope 1: 2,201 tCO2eRevenue: $M 1,122Scope 1 Intensity: 1.96 tCO2e/$MCCChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MJJJointown Pharmaceutical GroupYear: 2024Scope 1: 36,924 tCO2eRevenue: $M 20,801Scope 1 Intensity: 1.78 tCO2e/$M

How does Jointown Pharmaceutical Group's GHG emissions intensity compare to its peers?

In 2024, Jointown Pharmaceutical Group reported a Scope 1 emissions intensity of 1.78 tCO₂e per millions USD. Compared to the peer group median of 11.38 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Jointown Pharmaceutical Group rank on GHG emissions intensity within its industry?

In 2024, Jointown Pharmaceutical Group ranked 9 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Jointown Pharmaceutical Group is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Jointown Pharmaceutical Group's GHG Emissions Dataset?
Sign Up

Explore Peer Companies

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Healthcare
Medical Distribution
China (Mainland)

Sinopharm Group Co Ltd

Healthcare
Medical Distribution
China (Mainland)

JD Health International Inc

Healthcare
Pharmaceutical Retailers
China (Mainland)

Alphamab Oncology

Healthcare
Biotechnology
China (Mainland)

Ascletis Pharma Inc

Healthcare
Biotechnology
China (Mainland)

Shandong Weigao Group Medical Polymer Co Ltd

Healthcare
Medical Instruments & Supplies
China (Mainland)